Top Indian firms set for double-digit growth
This article was originally published in Scrip
Executive Summary
Leading Indian pharmaceutical companies are expected to report double digit earnings growth on a year-on-year basis for the last quarter ended 31 March 2013, though sequential quarterly growth is likely to be more moderate, according to a clutch of analysts polled by Scrip.